Editor's take: Microsoft has long been the financial lifeline of OpenAI, but its growing reliance on Anthropic's models suggests that loyalty may be giving way to performance. By favoring Anthropic in ...
Visual Studio Code now has a new auto AI model selector that favors Claude 4 over GPT-5. Visual Studio Code now has a new auto AI model selector that favors Claude 4 over GPT-5. is a senior editor and ...
What if your favorite coding tool just got smarter, faster, and more intuitive? That’s exactly what the latest update to Visual Studio Code (VS Code) promises. With a bold focus on AI integration, ...
The first preview of Visual Studio 2026, with deeper GitHub Copilot AI integration, is available through Microsoft’s new Insiders channel. Microsoft has released its first preview of the Visual Studio ...
What if you could build a fully functional app without ever touching a line of code? Imagine creating a tool that generates professional responses to emails, complete with AI-crafted images, all in ...
Cybersecurity researchers have called attention to a cyber attack in which unknown threat actors deployed an open-source endpoint monitoring and digital forensic tool called Velociraptor, illustrating ...
Arm Holdings (NASDAQ:ARM) has witnessed a significant surge in the number of customers using its chips in data centers, a 14-fold increase since 2021. This growth is attributed to the company’s ...
The “window terminated unexpectedly” error in Visual Studio Code occurs when one of the Electron renderer processes crashes or is forcefully shut down by the ...
The ‘Grey’s Anatomy’ star said he’s participating in a research study on ALS and hopeful about his future. The actor Eric Dane says he can no longer use his right arm because of ALS, a degenerative ...
Sacramento County will deploy drones to locate and assist remote homeless camps. Probation department plans to use drones for outreach, not surveillance or policing. Supervisors delayed decision on ...
SOGUG-NEOWIN: A phase 2, open-label, multicenter, multinational interventional trial evaluating the efficacy and safety of erdafitinib (ERDA) monotherapy and the combination of ERDA and cetrelimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results